3650 results for «505»

Filter By

3650 results

Best complications on calcified lesions

20 May 2026 – From EuroPCR 2026

Highlighting challenging cases in calcified coronary lesions, this session presents a series of complications including stuck wires, the Kokeshi phenomenon, and multiple complications within a single vessel. It provides practical insights into rescue techniques and navigating complex procedural challenges.

Best complications on calcified lesions

Unusual NSTEMI lesions and cases

19 May 2026 – From EuroPCR 2026

This session presents a collection of unusual NSTEMI cases characterized by atypical lesion patterns and diagnostic challenges. Topics include surprising unstable angina presentations, complex ostial lesions of the left circumflex artery, and the critical role of OCT imaging in preventing adverse outcomes.

CTO PCI: technical developments

19 May 2026 – From EuroPCR 2026

This session highlights technical developments in CTO PCI, featuring comparative insights from the ONUBA-CTO study on retrograde versus antegrade approaches, sex-based differences in long-term outcomes, management of balloon-undilatable lesions, the role of virtual reality audiovisual distraction, the impact of core laboratory feedback with OCT, and contemporary...

TAVI procedural complications - Part 5: vascular complications, coronary issues and more

20 May 2026 – From EuroPCR 2026

This session addresses procedural complications during TAVI, focusing on vascular complications, coronary issues, and rare device-related events. It includes case analyses of aortic dissection, valve infolding, stent dislodgement, and management strategies for complex anatomical challenges.

TAVI procedural complications - Part 5: vascular complications, coronary issues and more

Continued global expansion of Stent – Save a Life!

18 May 2023

There is no doubt that the original Stent for Life initiative had a huge, positive impact on morbidity and mortality in patients with STEMI in Europe. With the global Stent – Save a Life! (SSL) initiative comes the continued spread of the mission to other regions,...

Continued global expansion of Stent – Save a Life!

FFR or 3d-quantitative coronary angiography-based vessel-FFR guided revascularisation – The FAST III trial

28 Mar 2026

Chiara De Biase provides her take on the FAST III Trial presented by Joost Daemen at ACC.26 in New Orleans. She reviews the comparison between vFFR and FFR, highlighting key findings and their impact on revascularisation strategies.

Author

Chiara De Biase
FAST III: FFR vs 3D-QCA vessel-guided revascularisation

RESHAPE-HF2 - Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure

01 Sep 2024

Nicola Ryan provides her take on the RESHAPE-HF2 trial presented by Stefan Anker at the ESC Congress 2024 in London and simultaneously published in the NEJM.

The RESHAPE-HF 2 trial is a prospective randomised control trial comparing transcatheter mitral valve repair (TEER) and guideline-directed medical therapy to guideline-directed medical...

Nicola Ryan

Author

Nicola Ryan
RESHAPE-HF2

When transfemoral TAVI is not an option: rethinking alternative access strategies

18 Jun 2026

In this article, Ulrich Schäfer explores the evolving landscape of access strategies in transcatheter aortic valve implantation (TAVI). While the transfemoral approach remains the gold standard, a significant proportion of patients are not suitable due to peripheral vascular disease or anatomical constraints.
Drawing on clinical evidence and...

Author

Ulrich Schaefer
Alternative access, if transfemoral is not working

DAPT-SHOCK-AMI trial: Cangrelor in cardiogenic shock

03 Sep 2025

Kalaivani Mahadevan and Fizzah Choudry provide their take on DAPT-SHOCK-MI presented by Zuzana Motovska at ESC Congress 2025 in Madrid.

Fizzah Choudry

Author

Fizzah Choudry
Kalaivani Mahadevan

Author

Kalaivani Mahadevan
DAPT-SHOCK-AMI trial: Cangrelor in cardiogenic shock

Intravascular ultrasound-guided versus angiography-guided percutaneous coronary intervention in acute coronary syndromes: The multicenter, randomized, blinded, IVUS-ACS Trial

09 Apr 2024

Marco Spagnolo and Daniele Giacoppo report the main results of the IVUS-ACS trial presented by Shao-Liang Chen, from the Nanjing First Hospital, Nanjing Medical University, Nanjing, in a Featured Clinical Research session at ACC.24 in Atlanta and simultaneously published in The Lancet.(1)

Daniele Giacoppo

Author

Daniele Giacoppo
Marco Spagnolo

Author

Marco Spagnolo
IVUS-guided vs angiography-guided PCI in acute coronary syndromes
Didn’t find what you were looking for?